Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to compare the urinary viral microbiome and bacterial microbiome between overactive bladder syndrome (OAB) patients and healthy controls in order to determine a possible alteration in the urinary microbiome which may predispose women for OAB, and also in order to determine a possible influence of the urinary viral microbiome on the urinary bacterial microbiome which may predispose the individual to OAB. Furthermore, we aim to compare the urinary bacterial microbiome to the vaginal, rectal, urethral and salivary bacterial microbiome within the same individual and between the two groups in order to determine a possible route of colonization of the urinary bladder.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| overactive bladder syndrome | female patients with overactive bladder syndrome | ||
| controls | women without overactive bladder syndrome |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| urinary bacterial and viral microbiome | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| bacterial and viral microbiome of vagina, urethra, feces and oral cavity | 1 day |
Not provided
Inclusion Criteria (case group):
Exclusion Criteria (case group):
Pregnant or lactating females
Inclusion Criteria (control group):
without symptoms of overactive bladder or any other form of lower urinary tract symptoms
Exclusion criteria (control group):
As case group plus any form of lower urinary tract symptoms including OAB
Not provided
Not provided
Not provided
All patients bothering for OAB, who present themselves at the urogynecological outpatient clinic, are considered to be eligible for inclusion in this study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marianne Koch, MD PhD | Contact | +4314040029150 | marianne.koch@meduniwien.ac.at |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Vienna | Recruiting | Vienna | 1090 | Austria |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D053201 | Urinary Bladder, Overactive |
| ID | Term |
|---|---|
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |